Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico

@article{Sciutto2006FurtherEO,
  title={Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico},
  author={Edda Sciutto and J. Morales and J J Mart{\'i}nez and Andrea Toledo and M N Villalobos and Carmen Cruz-Revilla and Gabriela Meneses and M. Hern{\'a}ndez and Alicia Arias de D{\'i}az and L. F. Rodarte and Gonzalo Acero and Goar Gevorkian and Karen Manoutcharian and Jorge Paniagua and Gladis Fragoso and Agn{\`e}s Fleury and Rosa Larralde and Aline S. de Aluja and Carlos M. Larralde},
  journal={Parasitology},
  year={2006},
  volume={134},
  pages={129 - 133}
}
Taenia solium cysticercosis is a parasitic disease frequently affecting human health and the pig industry in many developing countries. A synthetic peptide vaccine (designated S3Pvac) against porcine cysticercosis has been developed previously as an aid to interrupt transmission and has been shown to be effective. The results of the present study support the effectiveness of the vaccine under endemic field conditions. However, given the time-frame of the vaccination trial, no changes in the… Expand
Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine.
TLDR
This review highlights the development of several versions of S3Pvac aimed to increase effectiveness, reduce costs and increase feasibility by novel delivery systems and alternative routes of administration. Expand
Development of the S3Pvac Vaccine Against Porcine Taenia solium Cysticercosis: A Historical Review
TLDR
Immunological results related to vaccination prove that protection is at least partially mediated by specific immunity and support the validity of T. crassiceps murine cysticercosis as an effective tool to identify vaccine candidates against some metacestode infections. Expand
Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis.
TLDR
In search of reducing vaccine production costs', a recombinant M13 phage version of the anti-cysticercosis tripeptide vaccine (S3Pvac) was developed and evaluated in a randomized trial that included 1,047 rural pigs in 16 villages of Central Mexico. Expand
RENEWED HOPE FOR A VACCINE AGAINST THE INTESTINAL ADULT TAENIA SOLIUM
Review of experimental and observational evidence about various cestode infections of mammalian hosts revives hope for the development of an effective vaccine against adult intestinal tapeworms, theExpand
Transmission biology of porcine cysticercosis in eastern-central Tanzania
TLDR
The ddPCR technology was found to be effective in detecting taeniid egg DNA from soil using spiked and field soil samples, however, the rate of soil contamination by T. solium egg DNA detected by the dd PCR in 96 surveyed households in the surveyed villages was low, suggesting a low risk of both pigs and humans acquiring cysticercosis through contaminated soil. Expand
A new highly effective anticysticercosis vaccine expressed in transgenic papaya.
The use of transgenic plants as new antigen-delivery systems for subunit vaccines has been increasingly explored. We herein report progress toward a papaya-based vaccine against cysticercosis.Expand
Identification and Control of Sources of Taenia Solium Infection – the Attempts To Eradicate the Parasite
TLDR
The purpose of the present review is to summarise current knowledge about diagnostic and control methods concerning T. solium infection, presenting the methods to detect and control porcine cysticercosis and taeniosis in humans. Expand
Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities
TLDR
A control scenario involving vaccination plus oxfendazole treatment delivered at 4 monthly intervals was predicted to achieve the best outcome, with no pigs slaughtered at 12 months of age having viable T. solium cysticerci. Expand
Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells
TLDR
A new oral plant-made version of the HP6/TSOL18 anti-cysticercosis vaccine is reported, and the vaccine candidate should be further tested against porcine cysticERCosis. Expand
Control of Taenia solium taeniasis/cysticercosis: The best way forward for sub-Saharan Africa?
TLDR
This manuscript looks critically into currently existing control options and provides suggestions on which (combination of) tools would be most effective in the control of T. solium taeniasis/cysticercosis in sub-Saharan Africa. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 33 REFERENCES
Induction of Protection against Porcine Cysticercosis by Vaccination with Recombinant Oncosphere Antigens
TLDR
Two recombinant Taenia solium oncosphere antigens, designated TSOL18 and TSOL45-1A, were investigated as vaccines to prevent transmission of the zoonotic disease cysticercosis through pigs and provide the basis for development of a highly effective practical vaccine that could assist in the control and, potentially, the eradication of human neurocysticERCosis. Expand
Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs.
TLDR
A statistically significant decline in the prevalence of porcine cysticercosis was observed at the end of the trial, and it may be possible to turn a susceptible pig population into a protected one by systematic vaccination. Expand
Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico.
TLDR
The natural challenge conditions used in this field trial strengthen the likelihood of successful transmission control to both pig and human through a large-scale pig vaccination program as these rather simple yet protective peptides are potentially more cost-effective to produce and less variable in results than antigens that are more complex. Expand
Vaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigens.
TLDR
These results, and those achieved elsewhere with Taenia saginata and T. ovis, support the possibility of developing a practical vaccine to assist in the control of transmission of T. solium through pigs. Expand
Vaccination of pigs to control human neurocysticercosis.
TLDR
A recombinant subunit vaccine based on oncosphere antigens has the potential to improve the available control measures for T. solium and thereby reduce or eliminate neurocysticercosis. Expand
Effective immune protection of pigs against cysticercosis.
TLDR
A scolex protein antigen (SPA) was prepared from cysticerci of Taenia solium obtained from naturally infected pigs and high titers of specific antibodies were detected in the sera of vaccinated animals and in infected controls. Expand
Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis.
TLDR
This is the first report describing the application of a filamentous bacteriophage as a vaccine in large animals such as pigs, the only intermediate hosts of T. solium, a parasite of major medical importance in developing countries. Expand
Towards a Taenia solium Cysticercosis Vaccine: an Epitope Shared by Taenia crassiceps and Taenia solium Protects Mice against Experimental Cysticercosis
TLDR
The remarkable protection induced by GK-1 immunization, its physicochemical properties, and its presence in all developmental stages of T. solium point to this synthetic peptide as a strong candidate in the construction of a synthetic vaccine againstT.solium pig cysticercosis. Expand
The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk.
TLDR
The current findings suggest the widespread presence of human tapeworm carriers and thus a high risk of human cysticercosis in both rural areas and urban centres in the ESA region. Expand
Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions.
TLDR
Current knowledge on human and porcine cysticercosis caused by Taenia solium is reviewed and current trends in research on its natural history, epidemiology, immunopathology, diagnosis, treatment and prevention are highlighted. Expand
...
1
2
3
4
...